The Gap Series · Essay 5 · Gut Health · Microbiome
Gastroenterology is a medical specialty. The gut, however, is not a specialised system. It connects to the brain, the immune system, the hormonal system, and the metabolic system in ways that make it arguably the most important organ in the body for understanding why someone is unwell. Treating it as a separate department is the first diagnostic mistake.
This is part of The Gap — a series of clinical essays on what medicine misses. Earlier essays cover reference ranges, women's health, stress physiology, and thyroid investigation.
There is a conversation I have had, in one form or another, hundreds of times across thirty-seven years.
It goes roughly like this. A person has been told they have IBS. Or functional dyspepsia. Or non-specific gut symptoms that don't fit any diagnosis cleanly. They have been given dietary advice — low FODMAP, perhaps, or simply "avoid foods that trigger symptoms." They may have been prescribed a PPI, or an antispasmodic, or told that stress management would help. They are managing. They are not well.
And then, somewhere in the conversation, they mention something that isn't obviously a gut symptom. Their mood has been low. Their skin has flared. They've been getting recurrent infections. Their joints ache in a way they didn't used to. They can't think clearly after meals. They're anxious in a way that feels physical rather than psychological.
These are not unrelated symptoms. They are expressions of the same underlying problem — seen from different angles by different specialists who haven't spoken to each other, and who are each treating their department rather than the person.
The gut is where this story usually starts. Not because everything is a gut problem, but because the gut connects to everything else — and when it's dysregulated, that dysregulation propagates outward into systems that appear, on the surface, to have nothing to do with digestion.
The gastrointestinal tract is approximately nine metres of tube running from mouth to anus. This description, accurate as far as it goes, substantially undersells what it contains.
The gut hosts approximately 38 trillion microbial cells — bacteria, archaea, fungi, viruses, and phages — in a community of such complexity that it is sometimes referred to as a virtual organ. The combined genetic content of the gut microbiome (the microbiome) is estimated to be 150 times that of the human genome. These microorganisms are not passengers. They are active participants in digestion, immune education, neurotransmitter synthesis, hormone metabolism, vitamin production, and the maintenance of the gut barrier itself.
The gut wall is a single cell layer thick in places — a boundary of extraordinary delicacy between the contents of the intestinal lumen and the systemic circulation. The tight junction proteins that hold these cells together are dynamic structures that open and close in response to signals from the microbiome, the immune system, the nervous system, and dietary inputs. When they become dysregulated — when intestinal permeability increases — the consequences extend far beyond the gut.
The gut contains approximately 70% of the body's immune tissue. The enteric nervous system — the network of neurons embedded in the gut wall — contains more nerve cells than the spinal cord. The gut produces more serotonin than the brain. These are not incidental features. They are the structural basis for the connections that make the gut, in clinical practice, inseparable from the systems that appear to sit above and beyond it.
The term "leaky gut" has had a difficult journey through medical culture — dismissed for years as alternative medicine, now increasingly acknowledged in mainstream gastroenterology research under its more precise names: increased intestinal permeability, barrier dysfunction, tight junction dysregulation.
What it describes is straightforward. The tight junctions between intestinal epithelial cells — the molecular seals that determine what passes from the gut lumen into systemic circulation — become more permeable under conditions of stress, dysbiosis, dietary irritants, alcohol, NSAIDs, and certain pathogens. When these seals loosen, molecules that should remain in the gut — bacterial fragments (LPS), partially digested food proteins, mycotoxins, and other compounds — enter the circulation and trigger immune responses.
The immune consequences are significant. LPS — a component of the outer membrane of gram-negative bacteria — is one of the most potent activators of the innate immune system known. When it enters systemic circulation via a permeable gut barrier, it triggers inflammatory cytokine production, activates mast cells, and drives a chronic low-grade inflammatory state that underpins a remarkable range of conditions: metabolic syndrome, cardiovascular disease, neurodegeneration, autoimmunity, mood disorders, and fatigue syndromes among them.
Food sensitivity — as distinct from food allergy — is largely a gut barrier story. IgG food reactions, which are what we measure on the IgG Food MAP, are not true allergies (which are IgE-mediated and immediate). They are markers of immune activation against food proteins that have crossed a permeable gut barrier and been presented to the immune system in a context that triggers a low-grade response. The food is often not the primary problem — the barrier is. Remove the food and the symptom burden often reduces. Repair the barrier and the food may no longer be a problem.
Treating IBS without investigating the microbiome is like treating a leaking roof with a bucket. You are managing the consequence of the problem, not the problem itself.
Gut dysbiosis is not simply "bad bacteria." It is a disruption of the complex ecological balance of the microbiome — which includes overgrowth of pathogenic or opportunistic organisms, depletion of beneficial species, loss of microbial diversity, and dysfunction in the metabolic outputs of the community as a whole.
The clinical presentations of significant dysbiosis are varied enough that they rarely announce themselves as gut problems to the person experiencing them:
Bloating, distension, and altered bowel habit are the obvious ones. But fatigue that worsens after meals, recurrent thrush or fungal infections, brain fog that tracks with gut symptoms, skin conditions including eczema and psoriasis that flare with dietary changes, joint pain that is worse after eating, recurrent sinus infections, and anxiety that has a physical, gut-centred quality to it — these are all consistent with significant dysbiosis and increased intestinal permeability, even when the person presenting them doesn't think of themselves as having a gut problem.
The organisms that matter most in a dysbiotic picture include:
H. pylori — present in approximately 44% of the UK population, often asymptomatic but consistently associated with gastric inflammation, impaired stomach acid production (which has downstream effects on protein digestion and mineral absorption), and increased risk of gastric ulcer and carcinoma. It depletes vitamin C and B12 from gastric mucosa. Its presence changes the gastric environment in ways that affect everything downstream.
Opportunistic bacteria — organisms like Klebsiella pneumoniae, Pseudomonas aeruginosa, Morganella morganii, and others that exist harmlessly at low levels in many people but, when overgrown, produce endotoxins, consume beneficial microbial space, and drive inflammatory and immune responses.
Parasites — Blastocystis hominis, Dientamoeba fragilis, Giardia lamblia, and others that are significantly underdiagnosed by standard stool testing (which relies on microscopy) and whose clinical effects range from mild digestive disruption to significant immune activation and nutrient malabsorption.
Candida and fungal overgrowth — relevant both as a primary gut pathogen and as a source of mycotoxins (as discussed in the mycotoxins post). Candida overgrowth is driven by antibiotic use, high-sugar diets, immune suppression, and gut barrier dysfunction, and itself perpetuates the conditions that sustain it.
Depleted keystone species — Faecalibacterium prausnitzii and Akkermansia muciniphila are two of the most researched beneficial bacteria in the gut. F. prausnitzii is the primary producer of butyrate — the short-chain fatty acid that serves as the primary fuel for colonocytes (the cells lining the colon) and has profound anti-inflammatory effects on the gut and systemically. Its depletion is consistently associated with inflammatory bowel conditions, metabolic disease, and colorectal cancer risk. Akkermansia maintains the gut mucus layer — the protective barrier that sits over the epithelium and acts as the first line of mucosal defence. Its depletion is associated with increased intestinal permeability, metabolic syndrome, and autoimmunity. Neither appears on a standard NHS stool test.
The GI-MAP — Gastrointestinal Microbial Assay Plus — is a comprehensive stool analysis using quantitative PCR technology to detect and quantify specific microbial DNA. This makes it significantly more sensitive than conventional stool microscopy for detecting parasites and pathogens, and it measures organisms that standard testing doesn't look for at all.
The IgG Food MAP — a panel of 190 foods tested for IgG antibody reactions — is one of the most misunderstood tests in functional medicine, both by those who dismiss it and those who rely on it too heavily.
IgG food reactions are not allergies. They do not cause anaphylaxis. They cause low-grade, delayed immune activation — symptoms that may appear hours or even days after exposure, which is why elimination diets are so difficult to navigate without testing.
But the critical clinical insight is this: the IgG reaction is not primarily a statement about the food. It is a statement about the gut barrier. Foods that cross an intact gut barrier in their properly digested form do not typically trigger IgG reactions. Foods that cross a permeable gut barrier as partially digested proteins encounter immune tissue that recognises them as foreign and mounts a response.
This means that a high-reactivity IgG panel is diagnostic information about gut barrier integrity, not a permanent list of foods to avoid. Eliminating reactive foods while the barrier remains permeable often produces a rotation of reactive foods — different ones emerge on retesting because the underlying problem (the permeability) hasn't been addressed. Repair the barrier, and the food reactivity often reduces substantially.
This is why the IgG Food MAP is most clinically useful when run alongside the GI-MAP — together they tell the gut story: what the microbiome is doing, where the barrier has been compromised, and which foods the immune system is currently reacting against as a consequence.
I want to return to the person described at the beginning — the one with IBS who also has low mood, recurrent infections, joint pain, and cognitive symptoms after meals.
The conventional medical encounter with this person produces a series of disconnected investigations: a gastroenterology referral that finds no structural pathology and recommends low FODMAP; a rheumatology referral that finds no inflammatory arthritis and recommends NSAIDs; a psychiatry or psychology referral for the mood symptoms; a dermatology referral for the skin.
Each specialist is doing their job competently within their department. The problem is that the departments don't communicate — and none of them is investigating the gut microbiome, the intestinal permeability, or the systemic inflammatory burden that is driving symptoms across all of the specialties simultaneously.
A GI-MAP showing significant H. pylori, depleted F. prausnitzii, elevated LPS antibodies, and elevated beta-glucuronidase is not a gut story. It is a whole-body story that begins in the gut. The fatigue, the mood, the joint symptoms, the hormonal picture, the cognitive symptoms — these are the downstream expression of a dysbiotic, permeable gut that has been creating systemic inflammatory burden for long enough that the consequences have scattered across multiple systems and multiple specialty waiting lists.
Treat the gut — specifically, targeted to what the GI-MAP actually shows — and watch what happens to the symptoms that appear to have nothing to do with it.
The eight-module Resilient Gut System programme was built specifically to address gut restoration in the right sequence: investigation first, then targeted intervention, then rebuild. It works best alongside a GI-MAP and IgG Food MAP that give it clinical direction rather than a generic protocol.
The DH Clinical Concierge can help you map the connections between what you're experiencing and what a proper gut investigation would reveal.
Talk to the Concierge